Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | TERT | O14746 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | PSMB5 | P28074 | 7/20 | 0.54 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29589893 | 1.00 | CYP1A2 (0.61) | CYP1A2TERTAPPKDM4ELMNA | |
| SCHEMBL2672636 | 0.88 | TERT (0.69) | CYP1A2TERTAPPKDM4ELMNA | |
| SCHEMBL2222093 | 0.85 | CYP1A2 (0.63) | CYP1A2TERTAPPKDM4ELMNA | |
| SCHEMBL12647016 | 0.80 | APP (0.71) | TERTAPPPSMB5EGFRAPAF1 | |
| SCHEMBL11322348 | 0.79 | TERT (0.61) | CYP1A2TERTKDM4ELMNAPOLB | |
| SCHEMBL17709258 | 0.78 | APP (0.55) | TERTAPPKDM4EPOLBCASP6 | |
| SCHEMBL5440195 | 0.78 | TERT (0.55) | TERTAPPPSMB5EGFRAPAF1 | |
| SCHEMBL11375051 | 0.77 | CYP1A2 (0.49) | CYP1A2TERTAPPKDM4ELMNA | |
| SCHEMBL12566471 | 0.77 | TERT (0.64) | TERTAPPKDM4EPSMB5EGFR | |
| SCHEMBL29444268 | 0.76 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAPOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4334008-A | PHOTORESISTS | BARD LABORATORIES, INC. (US) | 1982-06-08 | — | — | US | claimed |
| US-4312934-A | REACTIONOF AROMATIC AMINE OR HYDROXYLAMINE WITH POLYMER CONTAINING NITRATE GROUPS | BARD LABORATORIES, INC. (US) | 1982-01-26 | — | — | US | claimed |
| US-4049457-A | WITH AN ORGANIC ACID | BARD LABORATORIES, INC. (US) | 1977-09-20 | — | — | US | claimed |
| CN-116589404-B | Photosensitizer targeting beta amyloid protein and preparation method and application thereof | 华南理工大学 | 2026-05-15 | — | — | CN | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| EP-3442956-B1 | A PROCESS FOR THE PREPARATION OF PYRVINIUM PAMOATE AND CRYSTALLINE FORMS THEREOF | URQUIMA SA (ES) | 2024-03-27 | — | — | EP | disclosed |
| CN-116589404-A | Photosensitizer targeting beta amyloid protein and preparation method and application thereof | 华南理工大学 | 2023-08-15 | — | — | CN | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| CN-111978248-A | Multi-site modifiable aggregation-induced emission quinoline nitrile derivative, and preparation method and application thereof | 华东理工大学 | 2020-11-24 | — | — | CN | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-10646416-B2 | Microcapsules containing a gas-releasing photolabile compound and uses thereof | FIRMENICH SA (CH) | 2020-05-12 | — | — | US | disclosed |
| WO-2008128100-A1 | SMALL-MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-10-23 | — | — | WO | disclosed |
| CN-101106992-A | Novel quinolinium salts and derivatives | IMMUSOL INC (US) | 2008-01-16 | — | — | CN | disclosed |
| EP-1841428-A1 | NOVEL QUINOLINIUM SALTS AND DERIVATIVES | Immusol Incorporated (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006078754-A1 | NOVEL QUINOLINIUM SALTS AND DERIVATIVES | IMMUSOL INCORPORATED (US) | 2006-07-27 | — | — | WO | disclosed |
| US-4264710-A | AN ETHYLENICALLY UNSATURATED COMPOUND, AND A PHOTOPOLYMERIZATION INIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-4014877-A | MICROBIOCIDES | RIKER LABORATORIES, INC. (US) | 1977-03-29 | — | — | US | disclosed |
| US-4001243-A | ANTI-MICROBIAL | RIKER LABORATORIES, INC. (US) | 1977-01-04 | — | — | US | disclosed |
| US-3985882-A | ADMISTERING | RIKER LABORATORIES, INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3969463-A | MICROBIOCIDE | RIKER LABORATORIES, INC. (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10646416-B2 | Microcapsules containing a gas-releasing photolabile compound and uses thereof | ALOX5, TRPA1, FASN | CYP1A2 1863/4885TERT 4314/4885APP 621/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | CYP1A2 1592/4885TERT 2096/4885APP 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.